BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2526466)

  • 1. Further studies with 5E and 5Z analogues of PGI2 in platelets and vasculature.
    Oliva D; Giovanazzi S; Lograno M; Mongelli N; Corsini A; Fumagalli R; Nicosia S
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():172-5. PubMed ID: 2526466
    [No Abstract]   [Full Text] [Related]  

  • 2. (5Z)-carbacyclin displays agonist-antagonist properties on prostacyclin-receptors in platelets and vascular myocytes.
    Corsini A; Oliva D; Folco GC; Giovanazzi S; Noe' MA; Fumagalli R; Nicosia S
    Biomed Biochim Acta; 1988; 47(10-11):S104-7. PubMed ID: 3073757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin effects on adenylate cyclase in platelets and vascular smooth muscle: interaction with an inhibitory receptor or partial agonism?
    Rovati GE; Giovanazzi S; Negretti A; Nicosia S
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():263-5. PubMed ID: 7732849
    [No Abstract]   [Full Text] [Related]  

  • 4. (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.
    Corsini A; Folco GC; Fumagalli R; Nicosia S; Noe MA; Oliva D
    Br J Pharmacol; 1987 Jan; 90(1):255-61. PubMed ID: 3545351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGI2 receptors in vasculature and platelets: 5Z-carbacyclin discriminates between them.
    Nicosia S; Oliva D; Noè MA; Corsini A; Folco GC; Fumagalli R
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():474-8. PubMed ID: 2959100
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostacyclin-sensitive adenylate cyclase and prostacyclin binding sites in platelets and smooth muscle cells.
    Nicosia S; Oliva D; Bernini F; Fumagalli R
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():593-9. PubMed ID: 6328938
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological properties of the new stable prostacyclin analogue 3-Oxa-methano-prostaglandin I.
    Yamamoto T; Satoh K; Nishimura T; Horikawa N; Mine T; Hirohashi T; Hara Y
    Arzneimittelforschung; 1994 Apr; 44(4):483-90. PubMed ID: 8011001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exhibition of anti-platelet effect of isocarbacyclin methyl ester and its free acid via an increase in cAMP in platelets.
    Aoki Y; Inoue K; Kitahara S; Kiyoki M; Araki H
    Arzneimittelforschung; 1995 Sep; 45(9):970-4. PubMed ID: 7488315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium inhibits adenylate cyclase of human platelets.
    Imandt L; Tijhuis D; Wessels H; Haanen C
    Thromb Haemost; 1981 Apr; 45(2):142-5. PubMed ID: 6266068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of in vitro ethanol on prostaglandin E1-sensitive adenylate cyclase from smooth muscle cells and platelets.
    Noe M; Oliva D; Corsini A; Soma M; Fumagalli R; Nicosia S
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):293-308. PubMed ID: 4040929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between stimulators of adenylate and guanylate cyclases in human leukocytes, platelets and arteries.
    Gryglewski RJ; Korbut R; Kalecinska A; Zembowicz A
    Int J Tissue React; 1989; 11(6):269-75. PubMed ID: 2483990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of iloprost and sodium nitroprusside on vascular smooth muscle and platelet aggregation.
    Lidbury PS; Antunes E; de Nucci G; Vane JR
    Br J Pharmacol; 1989 Dec; 98(4):1275-80. PubMed ID: 2482103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gelfiltered platelets.
    Stürzebecher S; Nieuweboer B; Matthes S; Schillinger E
    Prog Clin Biol Res; 1989; 301():365-9. PubMed ID: 2477855
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological effects of (+/-)-11-deoxy, 16-phenoxy-prostaglandin E1 derivatives in the cardiovascular system.
    Banerjee AK; Tuffin DP; Walker JL
    Br J Pharmacol; 1985 Jan; 84(1):71-80. PubMed ID: 3884073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Keto-prostaglandin E1-sensitive adenylate cyclase and binding sites in membranes from platelets and cultured smooth muscle cells.
    Oliva D; Bernini F; Corsini A; Nicosia S
    Biochem Pharmacol; 1984 Dec; 33(23):3755-8. PubMed ID: 6391491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostacyclin.
    Weksler BB
    Prog Hemost Thromb; 1982; 6():113-38. PubMed ID: 6762610
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of arterial PGI2 generation and platelet aggregation by aspirin in rabbits ex vivo.
    Basista M
    Pol J Pharmacol Pharm; 1982; 34(5-6):317-21. PubMed ID: 6821216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulatory effects of vascular prostaglandins on the antiaggregatory activities of pentoxifylline acetylsalicylic acid combinations in vitro.
    Weithmann KU; Just M; Schlotte V; Seiffge D
    Vasa; 1989; 18(4):273-6. PubMed ID: 2514520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression and excitation induced in mice by two geometric isomers of (+)13,14-didehydro-20-methyl-carboprostacyclin, FCE 22177 and FCE 22176. Comparison with effects on blood pressure and platelet aggregation.
    Caparrotta L; Ceserani R; Mongelli N; Santi-Soncin E; Ragazzi E; Fassina G
    Prostaglandins; 1987 Mar; 33(3):351-62. PubMed ID: 3033748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.